Who has invested in Medopad?

Bayer AG are named among the investors backing Medopad.

Medopad Funding: $55M Raised, Series B (2019)

Medopad funding overview

Medopad is based in London, United Kingdom. Medopad has raised $55M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in November 2019. The round record for Medopad runs through 2019; nothing later has been disclosed. Investors on record include Bayer AG.

Medopad at a glance

Total raised: $55M
Latest round: Series B
Latest round date: November 2019
Headquarters: London, United Kingdom
Notable investors: Bayer AG

Frequently asked about Medopad funding

How much has Medopad raised?: Medopad has raised $55M in total disclosed funding across the rounds on record.
Who has invested in Medopad?: Bayer AG are named among the investors backing Medopad.
What was the latest Medopad funding round?: The most recent disclosed round is a Series B, announced in November 2019.
Where is Medopad based?: Medopad is based in London, United Kingdom.
When did Medopad last raise?: The last disclosed Medopad round closed in November 2019 at Series B.

We update the Medopad record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in London and their backers are listed below.

Medopad Funding: $55M Raised, Series B (2019)

Medopad funding overview

Medopad at a glance

Frequently asked about Medopad funding

Companies related to Medopad (18)

Browse related funding lists (5)